BioSpace News Archive

Business

Cellarity Appoints Head of Platform to Advance Vision for Novel Drug Creation

Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced the appointment of Christopher Woelk, Ph.D., as Vice President and Head of Platform.

May 7, 2024
·
3 min read
Nanox to Participate in Three Upcoming Investor Conferences in May 2024

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will participate in three investor conferences in the month of May 2024.

May 7, 2024
·
2 min read
Business

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

Journey Medical Corporation announced the Company will release its first quarter 2024 financial results after the U.S. financial markets close on Monday, May 13, 2024.

May 7, 2024
·
2 min read
Bio NC

Liquidia Corporation to Present at BofA Securities Health Care Conference 2024

Liquidia Corporation announced that Michael Kaseta, chief operating officer and chief financial officer, will provide an update on the company’s business during a fireside chat at the BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024, beginning at 5:00 p.m.

May 7, 2024
·
1 min read
Biotech Beach

Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program of Crinecerfont in CAH

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its neuroendocrinology pipeline, including baseline characteristics data from its CAHtalyst™ Program.

May 7, 2024
·
9 min read
Business

Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced its financial results for the first quarter of 2024 and provided a corporate update.

May 7, 2024
·
8 min read
Business

Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, reported financial results for the first quarter ended March 31, 2024.

May 7, 2024
·
15 min read
Business

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Denali Therapeutics Inc. reported financial results for the first quarter ended March 31, 2024, and provided business highlights.

May 7, 2024
·
13 min read
Business

ClearPoint Neuro Reports First Quarter 2024 Results

ClearPoint Neuro, Inc., a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announced financial results for its first quarter ended March 31, 2024.

May 7, 2024
·
12 min read
Business

Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program

Pacira BioSciences, Inc., the industry leader in its commitment to non-opioid pain management and regenerative health solutions, reported financial results for the first quarter of 2024.

May 7, 2024
·
27 min read